New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19
“Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms. That’s a lot of money for something that provenly doesn’t work it seems”
News on the Net , Bio and Archives--April 8, 2024
Health and Medicine | Comments | Reader Friendly | Subscribe | Email Us
New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19
“Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms. That’s a lot of money for something that provenly doesn’t work it seems.”
???? New NEJM Study Finds Pfizer’s Paxlovid Does ‘Little or Nothing’ for COVID-19
— Chief Nerd (@TheChiefNerd)April 7, 2024
“Kind of shocking a drug that costs $1,300…is showing in a randomized controlled trial to not really relieve COVID symptoms. That’s a lot of money for something that provenly doesn’t work it… pic.twitter.com/NWZV1ErSYu
View Comments
News from around the world